免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

USCOM in Newly Diagnosed FGR Cases

NCT:NCT06343051 · COMPLETED

NCT IDNCT06343051
狀態COMPLETED
開始日期2024-07-02
完成時間2026-05-07
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

簡要摘要

The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑